Anzeige
Mehr »
Login
Samstag, 04.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Bevorstehende News könnten diesen Kupfer-Explorer ins große Rampenlicht katapultieren
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
571 Leser
Artikel bewerten:
(2)

Pharmaceutical Excipients Market worth $11.5 billion by 2027 - Exclusive Report by MarketsandMarkets

Finanznachrichten News

CHICAGO, June 14, 2022 /PRNewswire/ -- According to the new market research report "Pharmaceutical Excipients Market by Product (Organic Chemicals (Carbohydrates), Inorganic Chemicals (Calcium Phosphate)), Functionality (Fillers, Binders, Lubricants, Preservatives), Formulation (Tablets, Capsules, Parenteral) - Global Forecast to 2027", published by MarketsandMarkets, the Pharmaceutical Excipients Market is projected to reach USD 11.5 billion by 2027 from USD 8.6 billion in 2022, at a CAGR of 5.9% during the forecast period of 2022 to 2027.

MarketsandMarkets_Logo

Browse in-depth TOC on "Pharmaceutical Excipients Market"
562 - Tables
51 - Figures
392 - Pages

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=956

The pharmaceutical excipient market is expected to grow at a CAGR of 5.9% during the forecast period. Growth in the market can be attributed to factors such as the pharmaceutical sector expansion and increasing uptake of biopharmaceuticals. Furthermore, the growing adoption of orphan drugs is also expected to fuel the market growth.

The inorganic chemicals segment accounted for the second largest share of the product segment in the pharmaceutical excipients market in 2021.

Inorganic chemicals generally comprise elements of mineral origin. These chemicals are broadly segmented into calcium compounds, such as calcium phosphate, calcium carbonate, and calcium sulfate; metal oxides; halites; and other inorganic chemicals. The performance properties of these chemicals is expected to drive inorganic chemicals segment demand thus fueling the pharmaceutical excipients during the forecast period

The suspending & viscosity agents segment accounted for the second largest share of the functionality segment in the pharmaceutical excipients market in 2021.

The second largest share of Suspending & Viscosity Agents segment can be attributed to the advantages of these agents. Suspensions prevent the caking of APIs at the bottom of a container by keeping them suspended; moderate shaking can restore suspension. Viscosity agents or viscosity modifiers change the thickness or texture of pharmaceutical ingredients. Such benefits of these agents such as stability for drugs along with appropriate viscosity is fueling its demand in the pharmaceutical industry.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=956

The Asia Pacific region is the fastest-growing region of the pharmaceutical excipients market in 2021.

The Asia Pacific is estimated to be the fastest-growing segment of the market. The growth of the pharmaceutical excipients markets of China and India is mostly driven by their low labor and manufacturing costs, which has drawn huge investments by pharma giants to these countries. The increasing disposable income, growing prevalence of lifestyle and age-related diseases, and government efforts to reform healthcare also contribute to the high growth of the regional market.

Key players in the pharmaceutical excipients market include Ashland Global Holdings, Inc (US), International Flavors & Fragrances, Inc. (US), BASF SE (Germany), Evonik Industries AG (Germany), Roquette Frères (France), Associated British Foods plc (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), Innophos Holdings (US), Kerry Group plc (Ireland), Wacker Chemie AG (Germany), Air Liquide (France), Dow Chemicals (US), Colorcon (US), DMV-Fonterra Excipients (Germany), JRS Pharma GmbH (Germany), Meggle GmbH & Co Kg (Germany), Finar Limited (India), Fuji Chemical Industries Co., Ltd (Japan), Merck KGaA (Germany), Captisol (US), Ideal Cures Pvt. Ltd (India), Corel Pharma Chem (India), Biogrund GmbH (Germany), Nitika Pharmaceutical Specialties Pvt. Ltd (India).

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=956

Browse Adjacent Markets: Pharmaceuticals Market Research Reports & Consulting

Browse Related Reports:

Tablet Coatings Market by Polymer (Cellulosic, Vinyl, Acrylic), Functionality (Delayed Release, Sustained Release), Type (Sugar Coated, Film Coated, Enteric Coated), End User (Pharmaceutical, Nutraceutical), COVID-19 Impact - Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/tablet-coatings-market-150774403.html

Active Pharmaceutical Ingredient (API) Market by type (Innovative, generic), manufacturer (captive, merchant), synthesis (synthetic, biotech), by product (vaccines, Hormones), drug (OTC, Rx), application (Diabetes, oncology, CVD) - Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/API-Market-263.html

About MarketsandMarkets

MarketsandMarkets provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/pharma-excipients-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/pharma-excipients.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg

© 2022 PR Newswire
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.